Loading…
One of China's largest home and hospital medical-device makers: blood pressure monitors, glucose meters, wheelchairs, oxygen concentrators.
One of China's largest home and hospital medical-device makers: blood pressure monitors, glucose meters, wheelchairs, oxygen concentrators.
Sells home devices in volume through pharmacy chains and online, and equipment to hospitals, so demand is split between consumers' routine purchases and hospital procurement. Oxygen concentrators and related devices surged in demand during the COVID years, and a wide product range gives it broad pharmacy shelf presence.
In one line: A Chinese Omron/Invacare hybrid for home medical devices.
Moat: narrow (scale, brand, distribution). Broad distribution and brand recognition across pharmacy and hospital channels in China.
Headquarters: Danyang, Jiangsu, China · Employees: 8,294
Size Jiangsu Yuyue Medical Equipment & Supply (002223.SZ) is a China Health Care company (Medical Specialties) with a market value of $4.26B, the 603rd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥28.93 on 6 Nov 2026.
Performance Over six months the shares fell 1.2%, against +28.3% for the median peer and -16.4% for the China market (cap-weighted) — 6th lowest of 21 in its peer set.
Growth Revenue fell 0.6% over the last twelve months (peer median +4.7%); the operating margin is 13.1% (peer median 13.1%).
Valuation It trades at 20.4× forward earnings against a peer median of 19.9× (9th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 5% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +2 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 2.6 points above its cost of capital (5.2% WACC).
Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥8.02B | CN¥7.90B | CN¥7.49B | CN¥7.89B | CN¥7.05B |
| Revenue growth | — | +6% | -5% | +12% | — |
| Gross profit | CN¥4.15B | CN¥3.82B | CN¥3.57B | CN¥3.86B | CN¥3.21B |
| EBITDA | n/a | CN¥1.45B | CN¥1.66B | CN¥2.29B | CN¥1.64B |
| Net income | CN¥1.15B | CN¥1.48B | CN¥1.81B | CN¥2.40B | CN¥1.60B |
| Free cash flow | CN¥1.09B | CN¥1.43B | CN¥1.69B | CN¥2.07B | CN¥2.04B |
| Capital expenditure | CN¥93.9M | CN¥129M | CN¥128M | CN¥133M | CN¥379M |
| Total debt | CN¥653M | CN¥683M | CN¥420M | CN¥1.61B | CN¥2.38B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply 002223.SZ | $4.26B | -1% | -1% | 13% | 20.4× | 5.1% |
| Omron 6645.T | $5.79B | -17% | -2% | 9% | 16.7× | 11.7% |
| Sinocare 300298.SZ | $1.58B | +15% | +7% | 6% | 23.6× | 10.8% |
| Shenzhen Mindray Bio-Medical Electronics 300760.SZ | $33.4B | +9% | +5% | 28% | 27.1× | 0.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002223.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +11.5% | +8.1% | 8th highest of 21 |
| 6-month return | -1.2% | +28.3% | 6th lowest of 21 |
| Distance from 52-week high | -37.5% | -15.3% | 4th lowest of 21 |
| Revenue growth (TTM) | -0.6% | +4.7% | 5th lowest of 20 |
| Operating margin | 13.1% | 13.1% | 10th highest of 20 |
| Forward P/E | 20.4× | 19.9× | 9th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 5.1% | 11.6% | 6th least demanding of 17 |
| Growth delivered (Del g) | +3.4% | +8.9% | 3rd lowest of 17 |
| Hurdle (Req g minus delivered) | +1.7 pp | +1.6 pp | 9th least demanding of 17 |
| ROIC minus cost of capital | +2.6 pp | +0.8 pp | 8th highest of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply 002223.SZ | China | $4.26B | -1% | -1% | 13% | 20.4× | 5.1% | +3.4% |
| Integer ITGR | United States | $4.30B | +44% | 0% | 9% | 18.8× | 19.6% | +11.5% |
| ICU Medical ICUI | United States | $4.30B | +36% | -9% | 7% | 19.5× | 22.1% | +11.9% |
| Intco Medical Technology 300677.SZ | China | $4.40B | -20% | +33% | 20% | 14.7× | -4.7% | -6.4% |
| CareDx CDNA | United States | $4.13B | +260% | +39% | 1% | 53.2× | n/a | n/a |
| Fielmann FIE.DE | Germany | $4.12B | +3% | +3% | 14% | 17.8× | -5.3% | +11.3% |
| Tecan TECN.SW | Switzerland | $4.05B | +91% | -4% | 1% | 40.1× | 46.9% | +3.8% |
| Envista NVST | United States | $4.04B | +4% | +12% | 11% | 15.6× | 6.8% | +7.1% |
| Sotera Health SHC | United States | $4.57B | +1% | +7% | 37% | 15.4× | 13.7% | +7.3% |
| Pulse Biosciences PLSE | United States | $3.87B | +179% | n/a | -7,008% | n/a | n/a | n/a |
| MiniMed MMED | United States | $4.70B | +44% | +14% | 14% | 25.5× | n/a | n/a |
| Stevanato STVN | United States | $3.70B | -26% | +12% | 18% | 19.3× | 10.6% | +12.1% |
| SCHOTT Pharma AG & Co. KGaA 1SXP.DE | Germany | $3.67B | +31% | +4% | 15% | 22.1× | 11.7% | +11.0% |
| LivaNova LIVN | United States | $4.96B | +25% | +12% | 13% | 19.9× | 11.5% | +8.2% |
| DiaSorin DIA.MI | Italy | $5.00B | +19% | -3% | 24% | 20.6× | 4.1% | +6.3% |
| Shandong Weigao Blood Purification Products 603014.SS | China | $3.63B | -3% | +4% | n/a | 20.4× | -1.2% | +8.1% |
| Andon Health 002432.SZ | China | $3.60B | -29% | -30% | -26% | 15.0× | -7.7% | -7.4% |
| iRay Technology 688301.SS | China | $3.54B | -8% | +58% | 24% | 27.5× | n/a | n/a |
| Carl Zeiss Meditec AFX.DE | Germany | $3.51B | +40% | 0% | 8% | 26.8× | 13.7% | +10.8% |
| Merit Medical Systems MMSI | United States | $5.23B | +42% | +9% | 14% | 19.4× | 12.2% | +9.5% |
| Ambu A/S AMBU-B.CO | Denmark | $3.42B | +40% | +5% | 11% | 28.1× | 12.6% | +11.1% |